To interpret these changes in dopamine 2 and 3 receptors (DRD2/3) receptor availability after weight loss needs an understanding of the effects of obesity or higher BMI itself on DRD2/3 receptor availability. The gene discussed is DRD2; the disease is obesity due to melanocortin 4 receptor deficiency.